Načítá se...
Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) accounts for 80–90% of primary liver tumors and is one of the most common and devastating malignant diseases worldwide. The MAPK signaling pathway is activated in over 90% of HCCs, and RKIP has been identified as an inhibitor of the MAPK pathway. It has been observed t...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3188396/ https://ncbi.nlm.nih.gov/pubmed/21984963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1615/ForumImmunDisTher.v2.i2.110 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|